NOVA Novamed, Inc. (MM)

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities and Exchange Act of 1934

Novamed, Inc.

 

(Name of Issuer)

Common Stock (Title of Class of Securities)

66986W207 (CUSIP Number)

December 31, 2010 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     This Schedule is filed pursuant to Rule 13d-1(b)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

CUSIP No.		66986W207

* This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

CUSIP No.		66986W207

* This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

1(a)		Name of Issuer:		Novamed, Inc.
1(b)		Address of Issuer’s Principal		333 W Wacker Dr., Suite 1010
		Executive Offices:		Chicago, IL 60606
2(a)		Name of Person Filing:		(a) Ameriprise Financial, Inc. (“AFI”)
				(b) Columbia Management Investment
				Advisers, LLC (“CMIA”)
2(b)		Address of Principal Business Office:		(a) Ameriprise Financial, Inc.
				145 Ameriprise Financial Center
				Minneapolis, MN 55474
				(b) 100 Federal St.
				Boston, MA 02110
2(c)		Citizenship:		(a) Delaware
				(b) Minnesota
2(d)		Title of Class of Securities:		Common Stock
2(e)		Cusip Number:		66986W207
3		Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):
		(a) Ameriprise Financial, Inc.
		A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
		(b) Columbia Management Investment Advisers, LLC
		An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E)
4		Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.
		AFI, as the parent company of CMIA, may be deemed to beneficially own the shares reported herein by CMIA. Accordingly, the shares reported herein by AFI include those shares separately reported herein by CMIA.
		Each of AFI and CMIA disclaims beneficial ownership of any shares reported on this Schedule.
5		Ownership of 5% or Less of a Class:
		If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ( ).

6		Ownership of more than 5% on Behalf of Another Person: Not Applicable
7		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
		AFI: See Exhibit I
8		Identification and Classification of Members of the Group:
		Not Applicable
9		Notice of Dissolution of Group:
		Not Applicable
10		Certification:
		By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 11, 2011

Exhibit Index

Exhibit I		Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.
Exhibit II		Joint Filing Agreement

Novamed (NASDAQ:NOVA)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Novamed (NASDAQ:NOVA)
Historical Stock Chart
Von Feb 2024 bis Feb 2025